These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9159324)

  • 1. Ovarian cancer screening and psychosocial issues: relevance to clinical practice.
    Basen-Engquist K
    Gynecol Oncol; 1997 May; 65(2):195-6. PubMed ID: 9159324
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychological impact of screening for familial ovarian cancer: reactions to initial assessment.
    Erlick Robinson G; Rosen BP; Bradley LN; Rockert WG; Carr ML; Cole DE; Murphy KJ
    Gynecol Oncol; 1997 May; 65(2):197-205. PubMed ID: 9159325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological distress associated with organized breast cancer screening.
    Steggles S; Lightfoot N; Sellick SM
    Cancer Prev Control; 1998 Oct; 2(5):213-20. PubMed ID: 10093635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for ovarian cancer-risk, education, worry: path to appropriate use?
    Skates SJ
    Gynecol Oncol; 2002 Apr; 85(1):1-2. PubMed ID: 11925112
    [No Abstract]   [Full Text] [Related]  

  • 5. Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study.
    Hipkins J; Whitworth M; Tarrier N; Jayson G
    Br J Health Psychol; 2004 Nov; 9(Pt 4):569-81. PubMed ID: 15509362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for abdominal aortic aneurysms does not increase psychological morbidity.
    Khaira HS; Herbert LM; Crowson MC
    Ann R Coll Surg Engl; 1998 Sep; 80(5):341-2. PubMed ID: 9849335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer.
    Bodurka-Bevers D; Basen-Engquist K; Carmack CL; Fitzgerald MA; Wolf JK; de Moor C; Gershenson DM
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):302-8. PubMed ID: 10985884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy.
    Ferrini R
    Am J Prev Med; 1997; 13(6):444-6. PubMed ID: 9415790
    [No Abstract]   [Full Text] [Related]  

  • 9. Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service.
    Söllner W; Maislinger S; König A; Devries A; Lukas P
    Psychooncology; 2004 Dec; 13(12):893-7. PubMed ID: 15457540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy.
    Bell R
    BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer screening.
    Macri CI; DiSaia PJ
    West J Med; 1992 Jun; 156(6):652-3. PubMed ID: 1615664
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM; Dørum A; Dahl AA
    Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for ovarian cancer: recommendations and rationale. American College of Physicians.
    Ann Intern Med; 1994 Jul; 121(2):141-2. PubMed ID: 8017728
    [No Abstract]   [Full Text] [Related]  

  • 16. The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up.
    Trimble EL
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S1-3. PubMed ID: 7835792
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovarian cancer screening: still waiting for the right answer.
    Ellwood D
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):447. PubMed ID: 19780722
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for ovarian cancer: not worthwhile for most patients.
    Wong JG; Feussner JR
    N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615
    [No Abstract]   [Full Text] [Related]  

  • 19. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood test for ovarian cancer may be 99% accurate.
    McBride D
    ONS Connect; 2008 Jun; 23(6):25. PubMed ID: 18572874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.